s type 2 diabetikere forsvandt de små forskelle imellem behandlingsgrupperne (0, 039 l til fordel for
In type 2 subjects, resolution of small treatment group differences (0.039L favouring comparator) occurred within 6 weeks of EXUBERA cessation following 2 years of therapy (Figure 3).